# Study of Anginera in Adults With a Left Ventricular Assist Device (LVAD) as Bridge to Transplant

> **NCT00364598** · PHASE1 · UNKNOWN · sponsor: **Theregen, Inc.** · enrollment: 15 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Anginera, a human tissue replacement therapy

## Key facts

- **NCT ID:** NCT00364598
- **Lead sponsor:** Theregen, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-12
- **Primary completion:** 2008-11
- **Final completion:** 2009-02
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2009-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00364598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00364598, "Study of Anginera in Adults With a Left Ventricular Assist Device (LVAD) as Bridge to Transplant". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00364598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*